drugset / Trial / NCT02355821

Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women

NCT02355821

RandomizedParallel-groupOpen-labelBasic science

Summary

This study evaluates the effect of moxonidine versus bisoprolol on collagen type 1 C-telopeptide in postmenopausal female patients with arterial hypertension and osteopenia.

Timeline

Start
2015-04
Primary completion
2018-06-15
Completion
2018-07-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bisoprolol Other / unclassified 7.5 mg
Subject Moxonidine Small molecule 0.6 mg